Evidence map›Paper›PMID 36482325›Full record

ArticleBMC gastroenterology2022

Exosomal microRNAs in the DLK1-DIO3 imprinted region derived from cancer-associated fibroblasts promote progression of hepatocellular carcinoma by targeting hedgehog interacting protein.

An-Li Jin, Lin Ding, Wen-Jing Yang, Te Liu, Wei Chen, Tong Li, Chun-Yan Zhang, Bai-Shen Pan, Shuang-Jian Qiu, Jian Zhou and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

An-Li Jin *Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Lin Ding *Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Wen-Jing YangDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Te LiuDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Wei ChenDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Tong LiDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Chun-Yan ZhangDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Bai-Shen PanDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Shuang-Jian QiuDepartment of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Jian ZhouDepartment of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Jia FanDepartment of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Wei GuoDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Xin-Rong YangDepartment of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. yang.xinrong@zs-hospital.sh.cn.
Bei-Li WangDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. wang.beili1@zs-hospital.sh.cn.
Fudan University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNZhongshan Hospital · CNMinistry of Education of the People's Republic of China · CNSun Yat-sen University · CN

Funding

Constructing Project of Clinical Key Disciplines in Shanghai shslczdzk03302Key Medical and Health Projects of Xiamen YDZX20193502000002National Key Research & Development Program of China 2019YFC1315800National Key Research & Development Program of China 2021YFC2501900National Natural Science Foundation of China grants 81772578National Natural Science Foundation of China grants 81902139National Natural Science Foundation of China grants 81972000Projects from Excellent backbone of Zhongshan Hospital, Fudan University 2021ZSGG08Projects from Science Foundation of Zhongshan Hospital, Fudan University 2021ZSCX28Projects from the Shanghai Municipal Health Commission 201940075Projects from the Shanghai Science and Technology Commission 21140900300Shanghai Medical Key Specialty ZK2019B28Shanghai Municipal Health Commission Collaborative Innovation Cluster Project 2019CXJQ02Shanghai "Rising Stars of Medical Talent" Youth Development Program Outstanding Youth Medical TalentsSpecialized Fund for the Clinical Researches of Zhongshan Hospital, Fudan University 2018ZSLC05Specialized Fund for the Clinical Researches of Zhongshan Hospital, Fudan University 2020ZSLC31State Key Program of National Natural Science of China grants 81830102
6 · The paper itself

Abstract

backgroundHepatocellular carcinoma (HCC) is the sixth most commonly diagnosed cancer and third leading cause of cancer-related death worldwide in 2020. Exosomes derived from cancer-associated fibroblasts (CAFs-exo) can promote tumor progression in various human cancers. However, the underlying regulatory mechanism controlling how CAFs-exo can promote HCC progression remains poorly understood.

methodsCAFs and para-cancer fibroblasts (PAFs) were isolated from HCC tissues and corresponding para-cancer tissues, then were cultured in vitro. CAFs and PAFs were characterized by immunofluorescence and western blot (WB) assays. Exosomes were isolated by ultracentrifugation, and characterized by transmission electron microscopy, nanoflow cytometry, and WB assay. The internalization of exosomes by HCC cells was observed under a fluorescence microscope. Cell Counting Kit-8 (CCK-8) assay was used to evaluate cell proliferation. Wound healing and transwell assays were used for migration and invasion experiments. RT-PCR assay was used to examine differentially expressed microRNAs (miRNAs) in exosomes and HCC cells. The TargetScan database was used to predict miRNA target genes. Hedgehog interacting protein (HHIP) expression analysis, prognostic analysis, and enrichment analysis of HHIP-related co-expressed genes were performed using the TIMER, UALCAN, Kaplan-Meier plotter, and LinkedOmics databases.

resultsCAFs-exo were internalized by HCC cells. CAFs-exo contributed to the aggressive phenotype of HCC cells, while inhibiting exosome secretion reversed these effects. Mechanistically, miRNAs in the DLK1-DIO3 imprinted region (miR-329-3p, miR-380-3p, miR-410-5p, miR-431-5p) were increased in HCC cells co-cultured with CAFs-exo compared with PAFs-exo. Expression of HHIP, a possible miR-431-5p target gene, was significantly downregulated in HCC cells. Low HHIP expression level in tumor tissues could predict poor prognosis in HCC patients. HHIP-related co-expressed genes were mainly associated with cell adhesion molecules.

conclusionsCAFs-exo can promote HCC progression by delivering miRNAs in the DLK1-DIO3 imprinted region to HCC cells, subsequently inhibiting HHIP expression. HHIP is a potential prognostic biomarker in HCC.

Indexed as

Cancer-Associated FibroblastsCarcinoma, HepatocellularLiver NeoplasmsMembrane GlycoproteinsMicroRNAsCalcium-Binding ProteinsCarrier ProteinsHumansMembrane ProteinsCalcium-Binding ProteinsCarrier ProteinsDLK1 protein, humanHHIP protein, humanMembrane GlycoproteinsMembrane ProteinsMicroRNAsMIRN329 microRNA, humanMIRN380 microRNA, humanMIRN410 microRNA, humanCancer-associated fibroblastsDLK1-DIO3 microRNA clusterExosomesHedgehog interacting proteinHepatocellular carcinoma

Identifiers

PMID36482325
PMCPMC9730585
OpenAlexW4311578419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.